Fitfile Group Secures £175k Seed Funding for Health Data Platform

London-based health data technology company Fitfile Group Limited has raised £175k in a Seed funding round. The investment brings the company's estimated post-money valuation to £6.3m.

Founded in March 2020, Fitfile provides a privacy-preserving data linkage and analytics platform designed for the healthcare and life sciences sectors. The technology enables the secure integration of health and consumer datasets, allowing organisations to generate real-time population health insights and identify patient cohorts. Crucially, the platform achieves this without moving or exposing sensitive personal identifiers, solving a major compliance and security hurdle in medical research and healthcare planning.

Headquartered in London, the company currently employs a team of 9 to 16 staff members based on recent corporate accounts and professional network data. Fitfile's customer base includes innovators across the life science, health system, and payor domains. The company states its core purpose is to transform the scale and value of health data usage to drive better clinical outcomes.

The £175k Seed round was allotted on 28 February 2026 and officially filed on 16 March 2026. The estimated £6.3m post-money valuation represents a marginal increase from the company's previous funding event. In December 2025, Fitfile completed a £2.1m Series A round at a £6.2m valuation. The sequence of a smaller Seed round following a Series A suggests this latest capital injection may act as a strategic top-up financing, maintaining a relatively flat valuation between the two closes.

Fitfile's latest funding aligns with a period of significant investment and structural growth within the UK health tech ecosystem. Industry data shows that UK health tech and life sciences startups raised £1.4 billion in venture capital during the first quarter of 2025 alone, making health the most funded sector in the country by a wide margin. By the end of 2024, the UK health tech startup ecosystem was valued at a combined £32 billion, with AI and data analytics companies accounting for over £1bn of historical funding.

Furthermore, the UK government's Autumn 2025 Budget committed £300m in new capital funding specifically for NHS technology. This mandate heavily prioritises upgrading digital systems, strengthening data infrastructure, and improving interoperability across healthcare providers.

As the regulatory environment around patient data becomes increasingly stringent, life science companies and healthcare systems are actively seeking compliant ways to leverage large-scale datasets. Fitfile's platform, which unites identifiable, pseudonymised, or irreversibly anonymised record-level data across institutional silos, positions the company to capitalise on the growing demand for safer and faster health data infrastructure.